All cards
1
Pre hypertension
Stage 1 HTN
Stage 2 HTN
Systolic 140-159 or diastolic 90-99
Stage 1 HTN
Stage 2 HTN
Systolic 140-159 or diastolic 90-99
stage 1
2
DUE or DUR
Broad, overall review of all drug use
Broad, overall review of all drug use
DUR
3
DUE or DUR
Focused evaluation of a specific drug or class.
Focused evaluation of a specific drug or class.
DUE
4
COI, CEA, CUA, CBA, CMA
what review of cost effetiveness is this Two generic brands of paracetamol have been proven to be bioequivalent and produce the same therapeutic effect. The
pharmacy chooses the one with the lower acquisition cost.
what review of cost effetiveness is this Two generic brands of paracetamol have been proven to be bioequivalent and produce the same therapeutic effect. The
pharmacy chooses the one with the lower acquisition cost.
CMA
5
COI, CEA, CUA, CBA, CMA
what review of cost effetiveness is this The government spends P100 million on a vaccination program and estimates it saves P350 million in future healthcare costs and productivity losses.
what review of cost effetiveness is this The government spends P100 million on a vaccination program and estimates it saves P350 million in future healthcare costs and productivity losses.
CBA
6
tx for gouty arthritis
AC-CA
acute gout- colchicine
chronic gout- allopurinol
probenecid
acute gout- colchicine
chronic gout- allopurinol
probenecid
7
other name of tophi in podagra
gouty arthritis
8
Which of the following is not a skill required for A CLINICAL PHARMACIST?
A.THERAPEUTIC PLANNING
B.DIAGNOSTIC
C.DRUG MONITORING
D: COMMUNICATANS
E. NO CORRECT ANSWER
A.THERAPEUTIC PLANNING
B.DIAGNOSTIC
C.DRUG MONITORING
D: COMMUNICATANS
E. NO CORRECT ANSWER
B
9
WHICH OF THE FOLLOWING IS NOT A GOAL OF PHARMACEUTICAL CARE?
A. ELIMINATION OF SYMPTOMS
B.CURE OF DISEASE
C. REDUCTION OF HEALTH CARE COSTS
D.PREVENTION OF DISEASE
E. NO CORRECT ANSWER
A. ELIMINATION OF SYMPTOMS
B.CURE OF DISEASE
C. REDUCTION OF HEALTH CARE COSTS
D.PREVENTION OF DISEASE
E. NO CORRECT ANSWER
C
10
Which of the following area doesn't follow the IPPA format?
A. Chest
B. Abdomen
C. Neck
D. AOTA
A. Chest
B. Abdomen
C. Neck
D. AOTA
B
11
An error occurred that resulted in either an initial or prolonged hospitalization, leading to temporary harm to the patient.
A. Cat G
B. Cat H
C. Cat F
D. Cat E
A. Cat G
B. Cat H
C. Cat F
D. Cat E
C
12
All are true when taking family history, except;
A. Only first degree members
B. Include those who passed away
C. Parents history
D. No exception
A. Only first degree members
B. Include those who passed away
C. Parents history
D. No exception
D
13
Patients smokes 60 cigarettes per day for the 30 years. What is the smoking pack years?
A. 20 pack years
B. 90 pack years
C. 30 pack years
D. NOTA
A. 20 pack years
B. 90 pack years
C. 30 pack years
D. NOTA
B
14
Thalidomide was famous in the late 1950s to early 60s as drug for what?
A. Morning Sickness
B. Flu
C. Nerve damage
D. Pneumonia
A. Morning Sickness
B. Flu
C. Nerve damage
D. Pneumonia
A
15
Hirsutism from Minoxidil is what type of ADR?
A. Type A
B.Type B
C.Type C
D. Type D
A. Type A
B.Type B
C.Type C
D. Type D
A
16
Which of the following drugs doesn't require TDM?
A. Diltiazem
B. Phenytoin
C. Methotrexate
D. Theophylline
A. Diltiazem
B. Phenytoin
C. Methotrexate
D. Theophylline
A
17
Which of the following is correct for Stage 4 CKD CrCI?
A. eGFR 10-19
B. eGFR 15-29
C. eGFR 30-39
D. eGFR less than 20
A. eGFR 10-19
B. eGFR 15-29
C. eGFR 30-39
D. eGFR less than 20
B
18
Category A, B, C, D, X
What pregnancy category is this Well-controlled studies in humans show no risk to the fetus
What pregnancy category is this Well-controlled studies in humans show no risk to the fetus
A
19
Category A, B, C, D, X
What pregnancy category is this
No well-controlled studies have been conducted in humans; animal studies show no risk to the fetus
What pregnancy category is this
No well-controlled studies have been conducted in humans; animal studies show no risk to the fetus
B
20
Category A, B, C, D, X
What pregnancy category is this No well-controlled studies have been conducted in humans; animal studies have demonstrated an adverse effect
on the fetus
What pregnancy category is this No well-controlled studies have been conducted in humans; animal studies have demonstrated an adverse effect
on the fetus
C
21
Category A, B, C, D, X
What pregnancy category is this Evidence of human risk to the fetus exists; however, benefits may outweigh risks in certain situations
What pregnancy category is this Evidence of human risk to the fetus exists; however, benefits may outweigh risks in certain situations
D
22
Category A, B, C, D, X
What pregnancy category is this Controlled studies in animals or humans demonstrate fetal abnormalities; the risk in pregnant women clearly
outweighs any possible benefit
What pregnancy category is this Controlled studies in animals or humans demonstrate fetal abnormalities; the risk in pregnant women clearly
outweighs any possible benefit
X
23
Category A, B, C, D, X
What pregnancy category is this folic acid
What pregnancy category is this folic acid
A
24
Category A, B, C, D, X
What pregnancy category is this metformin
What pregnancy category is this metformin
B
25
Category A, B, C, D, X
What pregnancy category is this amlodipine
What pregnancy category is this amlodipine
C
26
Category A, B, C, D, X
What pregnancy category is this Losartan
What pregnancy category is this Losartan
D
27
Category A, B, C, D, X
What pregnancy category is this
atorvastatin
What pregnancy category is this
atorvastatin
X
28
drugs under commonly monitored in TDM
TaLaCa MagPa DoTa
theophylline
lithium
cyclosporin
methotrexate
phenytoin
digoxin
tricylic antidepressant
theophylline
lithium
cyclosporin
methotrexate
phenytoin
digoxin
tricylic antidepressant
29
initiate what drugs?
30
initiate what drugs?
31
Stage 1,2,3 a or b,4,5
What stage of CKD is this 90 or higher
What stage of CKD is this 90 or higher
1
32
Stage 1,2,3 a or b,4,5
What stage of CKD is this 60-89
What stage of CKD is this 60-89
2
33
Stage 1,2,3 a or b,4,5
What stage of CKD is this 45-59
What stage of CKD is this 45-59
3a
34
Stage 1,2,3 a or b,4,5
What stage of CKD is this 15-29
What stage of CKD is this 15-29
4
35
Stage 1,2,3 a or b,4,5
What stage of CKD is this 30-44
What stage of CKD is this 30-44
3b
36
Stage 1,2,3 a or b,4,5
What stage of CKD is this less than 15
What stage of CKD is this less than 15
5
37
sulfonamides associated this side effects
sjs
38
methyldopa associated this side effects
hemolytic
39
chloramphenicol associated this side effects
aplastic anemina
40
Pre hypertension
Stage 1 HTN
Stage 2 HTN
Systolic 120-139 or 80-89 diastolic
Stage 1 HTN
Stage 2 HTN
Systolic 120-139 or 80-89 diastolic
pre hyper
41
INSPECTION
PALPATION
PERCUSSION
AUSCULTATION
Touch or feel using hands
PALPATION
PERCUSSION
AUSCULTATION
Touch or feel using hands
palpation
42
INSPECTION
PALPATION
PERCUSSION
AUSCULTATION
Visual observation
PALPATION
PERCUSSION
AUSCULTATION
Visual observation
inspection
43
INSPECTION
PALPATION
PERCUSSION
AUSCULTATION
TAPPING OF FINGERS TO PRODUCE “SOUND”
PALPATION
PERCUSSION
AUSCULTATION
TAPPING OF FINGERS TO PRODUCE “SOUND”
percussion
44
RESPONSIBLE PROVISION OF DRUG THERAPY FOR THE PURPOSE OF ACHIEVING DEFINITE OUTCOMES AND IMPROVEMENT OF THE PATIENTS’ QUALITY OF LIFE”
pharmaceutical care
45
what error category from A, B, C, D, E , F , G , H, I is this circumstances or events that have the capacity to cause error
A
46
what error category from A, B, C, D, E , F , G , H, I is this error occurred but the medication did not reach the patient
B
47
what error category from A, B, C, D, E , F , G , H, I is this error reaches the patient but did not cause harm
C
48
what error category from A, B, C, D, E , F , G , H, I is this error occurred that resulted in the need for increased patient monitoring but no patient harm
D
49
what error category from A, B, C, D, E , F , G , H, I is this error occurred that resulted in the need for treatment or intervention and caused temporary patient harm
E
50
what error category from A, B, C, D, E , F , G , H, I is this error occurred that resulted in initial or prolonged hospitalization and caused temporary patient harm
F
51
what error category from A, B, C, D, E , F , G , H, I is this error resulted in permanent patient harm
G
52
what error category from A, B, C, D, E , F , G , H, I is this error resulted in patient death
I
53
what error category from A, B, C, D, E , F , G , H, I is this error resulted in near death event
H
54
who defined pharmaceutical care
charles D. Hepler and linda M. Strand
55
PHARMACOVIGILANCE or Pharmacoepidemiology
CONTINUAL MONITORING OF UNWANTED EFFECTS AND OTHER SAFETY RELATED ASPECTS OF MARKETED DRUGS
CONTINUAL MONITORING OF UNWANTED EFFECTS AND OTHER SAFETY RELATED ASPECTS OF MARKETED DRUGS
pharmacovigilance
56
PHARMACOVIGILANCE or Pharmacoepidemiology
use and effects of drugs in large number of people
use and effects of drugs in large number of people
Pharmacoepidemiology
57
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this diuretics
What type of ADR is this diuretics
A
58
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this insulin
What type of ADR is this insulin
A
59
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this antihistamine
What type of ADR is this antihistamine
A
60
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this codeine
What type of ADR is this codeine
A
61
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this minoxidil
What type of ADR is this minoxidil
A
62
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this B Lactams
What type of ADR is this B Lactams
B
63
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this chloramphenicol
What type of ADR is this chloramphenicol
B
64
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this methyldopa
What type of ADR is this methyldopa
B
65
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this sulfonamide
What type of ADR is this sulfonamide
B
66
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this alcohol
What type of ADR is this alcohol
C
67
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this opiods
What type of ADR is this opiods
C
68
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this caffeine
What type of ADR is this caffeine
c
69
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this withdrawal symptoms
What type of ADR is this withdrawal symptoms
c
70
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this thalidomide
What type of ADR is this thalidomide
D teratogenic
71
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this valproic
What type of ADR is this valproic
D
72
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this phenytoin
What type of ADR is this phenytoin
D
73
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this retinoid
What type of ADR is this retinoid
D
74
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this ACE, ARB
What type of ADR is this ACE, ARB
D
75
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this lithium
What type of ADR is this lithium
D
76
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this oral contraceptive
What type of ADR is this oral contraceptive
D
77
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this warfarin
What type of ADR is this warfarin
D
78
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this rebound effect
What type of ADR is this rebound effect
E
79
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this steroid
What type of ADR is this steroid
E
80
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this clonidine
What type of ADR is this clonidine
E
81
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this wrong diagnosis
What type of ADR is this wrong diagnosis
F
82
Type A, Type B, Type C , Type D, Type E , Type F
What type of ADR is this non compliance
What type of ADR is this non compliance
F